• レポートコード:QY20ST-06477 • 出版社/出版日:QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、149ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品、医療 |
Single User | ¥580,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥870,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の経皮/経粘膜ドラッグデリバリーシステム市場について種類別(経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム)、用途別(病院、クリニック、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・経皮/経粘膜ドラッグデリバリーシステム市場の概要 ・世界の主要地域別経皮/経粘膜ドラッグデリバリーシステム市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の経皮/経粘膜ドラッグデリバリーシステム市場規模2015-2026:種類別(経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム) ・世界の経皮/経粘膜ドラッグデリバリーシステム市場規模2015-2026:用途別(病院、クリニック、その他) ・経皮/経粘膜ドラッグデリバリーシステムの北米市場規模2015-2020 ・経皮/経粘膜ドラッグデリバリーシステムのヨーロッパ市場規模2015-2020 ・経皮/経粘膜ドラッグデリバリーシステムの中国市場規模2015-2020 ・経皮/経粘膜ドラッグデリバリーシステムの日本市場規模2015-2020 ・経皮/経粘膜ドラッグデリバリーシステムの東南アジア市場規模2015-2020 ・経皮/経粘膜ドラッグデリバリーシステムのインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・経皮/経粘膜ドラッグデリバリーシステムの製造コスト分析 ・販売チャネル、流通業者、顧客 ・経皮/経粘膜ドラッグデリバリーシステムの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Transdermal/Transmucosal Drug Delivery System Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Transdermal/Transmucosal Drug Delivery System market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Transdermal/Transmucosal Drug Delivery System market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Transdermal/Transmucosal Drug Delivery System industry.
Based on our recent survey, we have several different scenarios about the Transdermal/Transmucosal Drug Delivery System YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Transdermal/Transmucosal Drug Delivery System will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Transdermal/Transmucosal Drug Delivery System market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Transdermal/Transmucosal Drug Delivery System market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Transdermal/Transmucosal Drug Delivery System market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Transdermal/Transmucosal Drug Delivery System market. The report also includes nautical information, where it shows Transdermal/Transmucosal Drug Delivery System market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Transdermal/Transmucosal Drug Delivery System market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Transdermal/Transmucosal Drug Delivery System market.
Geographical Analysis:
Based on region, the global Transdermal/Transmucosal Drug Delivery System market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Transdermal/Transmucosal Drug Delivery System market are
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Mylan
Teva
Zosano Pharma
Segment by Type
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Segment by Application
Hospitals
Clinics
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Transdermal/Transmucosal Drug Delivery System market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Transdermal/Transmucosal Drug Delivery System market.
• The market share of the global Transdermal/Transmucosal Drug Delivery System market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Transdermal/Transmucosal Drug Delivery System market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Transdermal/Transmucosal Drug Delivery System market.
1 Transdermal/Transmucosal Drug Delivery System Market Overview
1.1 Transdermal/Transmucosal Drug Delivery System Product Scope
1.2 Transdermal/Transmucosal Drug Delivery System Segment by Type
1.2.1 Global Transdermal/Transmucosal Drug Delivery System Sales by Type (2020-2026)
1.2.2 Transdermal Drug Delivery System
1.2.3 Transmucosal Drug Delivery System
1.3 Transdermal/Transmucosal Drug Delivery System Segment by Application
1.3.1 Global Transdermal/Transmucosal Drug Delivery System Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Transdermal/Transmucosal Drug Delivery System Market Estimates and Forecasts (2015-2026)
1.4.1 Global Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2026)
1.4.2 Global Transdermal/Transmucosal Drug Delivery System Revenue and Growth Rate (2015-2026)
1.4.3 Global Transdermal/Transmucosal Drug Delivery System Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Transdermal/Transmucosal Drug Delivery System Industry Impact
1.5.1 How the Covid-19 is Affecting the Transdermal/Transmucosal Drug Delivery System Industry
1.5.1.1 Transdermal/Transmucosal Drug Delivery System Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Transdermal/Transmucosal Drug Delivery System Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Transdermal/Transmucosal Drug Delivery System Players to Combat Covid-19 Impact
2 Transdermal/Transmucosal Drug Delivery System Estimate and Forecast by Region
2.1 Global Transdermal/Transmucosal Drug Delivery System Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Transdermal/Transmucosal Drug Delivery System Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Region (2015-2020)
2.2.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Region (2015-2020)
2.3 Global Transdermal/Transmucosal Drug Delivery System Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Transdermal/Transmucosal Drug Delivery System Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2015-2026)
2.4.2 Europe Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2015-2026)
2.4.3 China Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2015-2026)
2.4.4 Japan Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2015-2026)
2.4.6 India Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2015-2026)
3 Global Transdermal/Transmucosal Drug Delivery System Competition Landscape by Players
3.1 Global Top Transdermal/Transmucosal Drug Delivery System Players by Sales (2015-2020)
3.2 Global Top Transdermal/Transmucosal Drug Delivery System Players by Revenue (2015-2020)
3.3 Global Transdermal/Transmucosal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal/Transmucosal Drug Delivery System as of 2019)
3.4 Global Transdermal/Transmucosal Drug Delivery System Average Price by Company (2015-2020)
3.5 Manufacturers Transdermal/Transmucosal Drug Delivery System Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Transdermal/Transmucosal Drug Delivery System Players (Opinion Leaders)
4 Global Transdermal/Transmucosal Drug Delivery System Market Size by Type
4.1 Global Transdermal/Transmucosal Drug Delivery System Historic Market Review by Type (2015-2020)
4.1.1 Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
4.1.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Type (2015-2020)
4.1.3 Global Transdermal/Transmucosal Drug Delivery System Price by Type (2014-2020)
4.2 Global Transdermal/Transmucosal Drug Delivery System Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Transdermal/Transmucosal Drug Delivery System Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Forecast by Type (2021-2026)
4.2.3 Global Transdermal/Transmucosal Drug Delivery System Price Forecast by Type (2021-2026)
5 Global Transdermal/Transmucosal Drug Delivery System Market Size by Application
5.1 Global Transdermal/Transmucosal Drug Delivery System Historic Market Review by Application (2015-2020)
5.1.1 Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
5.1.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Application (2015-2020)
5.1.3 Global Transdermal/Transmucosal Drug Delivery System Price by Application (2015-2020)
5.2 Global Transdermal/Transmucosal Drug Delivery System Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Transdermal/Transmucosal Drug Delivery System Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal/Transmucosal Drug Delivery System Price Forecast by Application (2021-2026)
3 North America Transdermal/Transmucosal Drug Delivery System Market Facts & Figures
3.2 North America Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
3.3 North America Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
3.4 North America Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
4 Europe Transdermal/Transmucosal Drug Delivery System Market Facts & Figures
4.2 Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
4.3 Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
4.4 Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
5 China Transdermal/Transmucosal Drug Delivery System Market Facts & Figures
5.2 China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
5.3 China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
5.4 China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
6 Japan Transdermal/Transmucosal Drug Delivery System Market Facts & Figures
6.2 Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
6.3 Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
6.4 Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
7 Southeast Asia Transdermal/Transmucosal Drug Delivery System Market Facts & Figures
7.2 Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
8 India Transdermal/Transmucosal Drug Delivery System Market Facts & Figures
8.2 India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
8.3 India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
8.4 India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Transdermal/Transmucosal Drug Delivery System Business
12.1 3M
12.1.1 3M Transdermal/Transmucosal Drug Delivery System Corporation Information
12.1.2 3M Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.1.3 3M Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.1.4 3M Transdermal/Transmucosal Drug Delivery System Products Offered
12.1.5 3M Recent Development
12.2 Antares Pharma
12.2.1 Antares Pharma Transdermal/Transmucosal Drug Delivery System Corporation Information
12.2.2 Antares Pharma Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.2.3 Antares Pharma Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Antares Pharma Transdermal/Transmucosal Drug Delivery System Products Offered
12.2.5 Antares Pharma Recent Development
12.3 Aveva Drug Delivery Systems
12.3.1 Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Corporation Information
12.3.2 Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.3.3 Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Products Offered
12.3.5 Aveva Drug Delivery Systems Recent Development
12.4 Corium International
12.4.1 Corium International Transdermal/Transmucosal Drug Delivery System Corporation Information
12.4.2 Corium International Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.4.3 Corium International Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Corium International Transdermal/Transmucosal Drug Delivery System Products Offered
12.4.5 Corium International Recent Development
12.5 DURECT
12.5.1 DURECT Transdermal/Transmucosal Drug Delivery System Corporation Information
12.5.2 DURECT Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.5.3 DURECT Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.5.4 DURECT Transdermal/Transmucosal Drug Delivery System Products Offered
12.5.5 DURECT Recent Development
12.6 Pantec Biosolutions
12.6.1 Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Corporation Information
12.6.2 Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.6.3 Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Products Offered
12.6.5 Pantec Biosolutions Recent Development
12.7 Tapemark
12.7.1 Tapemark Transdermal/Transmucosal Drug Delivery System Corporation Information
12.7.2 Tapemark Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.7.3 Tapemark Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Tapemark Transdermal/Transmucosal Drug Delivery System Products Offered
12.7.5 Tapemark Recent Development
12.8 Tesa Labtec
12.8.1 Tesa Labtec Transdermal/Transmucosal Drug Delivery System Corporation Information
12.8.2 Tesa Labtec Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.8.3 Tesa Labtec Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Tesa Labtec Transdermal/Transmucosal Drug Delivery System Products Offered
12.8.5 Tesa Labtec Recent Development
12.9 Mylan
12.9.1 Mylan Transdermal/Transmucosal Drug Delivery System Corporation Information
12.9.2 Mylan Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.9.3 Mylan Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Mylan Transdermal/Transmucosal Drug Delivery System Products Offered
12.9.5 Mylan Recent Development
12.10 Teva
12.10.1 Teva Transdermal/Transmucosal Drug Delivery System Corporation Information
12.10.2 Teva Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.10.3 Teva Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Transdermal/Transmucosal Drug Delivery System Products Offered
12.10.5 Teva Recent Development
12.11 Zosano Pharma
12.11.1 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Corporation Information
12.11.2 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Business Overview and Total Revenue
12.11.3 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Products Offered
12.11.5 Zosano Pharma Recent Development
13 Transdermal/Transmucosal Drug Delivery System Manufacturing Cost Analysis
13.1 Transdermal/Transmucosal Drug Delivery System Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Transdermal/Transmucosal Drug Delivery System
13.4 Transdermal/Transmucosal Drug Delivery System Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Transdermal/Transmucosal Drug Delivery System Distributors List
14.3 Transdermal/Transmucosal Drug Delivery System Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Transdermal/Transmucosal Drug Delivery System Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Transdermal/Transmucosal Drug Delivery System Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Transdermal/Transmucosal Drug Delivery System Players to Combat Covid-19 Impact
Table 8. Global Market Transdermal/Transmucosal Drug Delivery System Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Region (2015-2020)
Table 10. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Region (2015-2020)
Table 11. Global Transdermal/Transmucosal Drug Delivery System Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Region (2015-2020)
Table 13. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Transdermal/Transmucosal Drug Delivery System Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Transdermal/Transmucosal Drug Delivery System Revenue Share Forecast by Region (2021-2026)
Table 17. Global Transdermal/Transmucosal Drug Delivery System (K Units) of Key Companies (2015-2020)
Table 18. Global Transdermal/Transmucosal Drug Delivery System Sales Share by Company (2015-2020)
Table 19. Global Transdermal/Transmucosal Drug Delivery System Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Company (2015-2020)
Table 21. Global Transdermal/Transmucosal Drug Delivery System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal/Transmucosal Drug Delivery System as of 2019)
Table 22. Global Transdermal/Transmucosal Drug Delivery System Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Transdermal/Transmucosal Drug Delivery System Manufacturing Sites and Area Served
Table 24. Manufacturers Transdermal/Transmucosal Drug Delivery System Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Transdermal/Transmucosal Drug Delivery System Players
Table 27. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 28. Global Transdermal/Transmucosal Drug Delivery System Sales Share by Type (2015-2020)
Table 29. Global Transdermal/Transmucosal Drug Delivery System Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Transdermal/Transmucosal Drug Delivery System Price (K Units) by Type (2015-2020)
Table 31. Global Transdermal/Transmucosal Drug Delivery System Sales Share by Type (2021-2026)
Table 32. Global Transdermal/Transmucosal Drug Delivery System Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Type (2021-2026)
Table 34. Global Transdermal/Transmucosal Drug Delivery System Price (K Units) by Type (2021-2026)
Table 35. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 36. Global Transdermal/Transmucosal Drug Delivery System Sales Share by Application (2015-2020)
Table 37. Global Transdermal/Transmucosal Drug Delivery System Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Transdermal/Transmucosal Drug Delivery System Price (K Units) by Application (2015-2020)
Table 39. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Application (2021-2026)
Table 40. Global Transdermal/Transmucosal Drug Delivery System Sales Share by Application (2021-2026)
Table 41. Global Transdermal/Transmucosal Drug Delivery System Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Application (2021-2026)
Table 43. Global Transdermal/Transmucosal Drug Delivery System Price (K Units) by Application (2021-2026)
Table 44. United States Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 45. United States Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
Table 46. United States Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 47. United States Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
Table 48. United States Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 49. United States Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
Table 50. Europe Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 51. Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
Table 52. Europe Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 53. Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
Table 54. Europe Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 55. Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
Table 56. China Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 57. China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
Table 58. China Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 59. China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
Table 60. China Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 61. China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
Table 62. Japan Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 63. Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
Table 64. Japan Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 65. Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
Table 66. Japan Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 67. Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
Table 74. India Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Company (2015-2020)
Table 75. India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company (2015-2020)
Table 76. India Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 77. India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
Table 78. India Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 79. India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
Table 80. 3M Corporation Information
Table 81. 3M Description and Business Overview
Table 82. 3M Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. 3M Transdermal/Transmucosal Drug Delivery System Product
Table 84. 3M Recent Development
Table 85. Antares Pharma Corporation Information
Table 86. Antares Pharma Description and Business Overview
Table 87. Antares Pharma Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Antares Pharma Transdermal/Transmucosal Drug Delivery System Product
Table 89. Antares Pharma Recent Development
Table 90. Aveva Drug Delivery Systems Corporation Information
Table 91. Aveva Drug Delivery Systems Description and Business Overview
Table 92. Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Product
Table 94. Aveva Drug Delivery Systems Recent Development
Table 95. Corium International Corporation Information
Table 96. Corium International Description and Business Overview
Table 97. Corium International Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Corium International Transdermal/Transmucosal Drug Delivery System Product
Table 99. Corium International Recent Development
Table 100. DURECT Corporation Information
Table 101. DURECT Description and Business Overview
Table 102. DURECT Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. DURECT Transdermal/Transmucosal Drug Delivery System Product
Table 104. DURECT Recent Development
Table 105. Pantec Biosolutions Corporation Information
Table 106. Pantec Biosolutions Description and Business Overview
Table 107. Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Product
Table 109. Pantec Biosolutions Recent Development
Table 110. Tapemark Corporation Information
Table 111. Tapemark Description and Business Overview
Table 112. Tapemark Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Tapemark Transdermal/Transmucosal Drug Delivery System Product
Table 114. Tapemark Recent Development
Table 115. Tesa Labtec Corporation Information
Table 116. Tesa Labtec Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Tesa Labtec Description and Business Overview
Table 118. Tesa Labtec Transdermal/Transmucosal Drug Delivery System Product
Table 119. Tesa Labtec Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Mylan Description and Business Overview
Table 123. Mylan Transdermal/Transmucosal Drug Delivery System Product
Table 124. Mylan Recent Development
Table 125. Teva Corporation Information
Table 126. Teva Description and Business Overview
Table 127. Teva Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Teva Transdermal/Transmucosal Drug Delivery System Product
Table 129. Teva Recent Development
Table . Zosano Pharma Corporation Information
Table . Zosano Pharma Description and Business Overview
Table . Zosano Pharma Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Zosano Pharma Transdermal/Transmucosal Drug Delivery System Product
Table . Zosano Pharma Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Transdermal/Transmucosal Drug Delivery System Distributors List
Table 138. Transdermal/Transmucosal Drug Delivery System Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal/Transmucosal Drug Delivery System Product Picture
Figure 2. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Transdermal/Transmucosal Drug Delivery System Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Others Examples
Figure 9. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Transdermal/Transmucosal Drug Delivery System Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Transdermal/Transmucosal Drug Delivery System Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Transdermal/Transmucosal Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Transdermal/Transmucosal Drug Delivery System Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Transdermal/Transmucosal Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Transdermal/Transmucosal Drug Delivery System Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Transdermal/Transmucosal Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Transdermal/Transmucosal Drug Delivery System Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Transdermal/Transmucosal Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Transdermal/Transmucosal Drug Delivery System Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Transdermal/Transmucosal Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Transdermal/Transmucosal Drug Delivery System Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Transdermal/Transmucosal Drug Delivery System Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Transdermal/Transmucosal Drug Delivery System Players Market Share by Revenue in Transdermal/Transmucosal Drug Delivery System 2015 & 2019
Figure 27. Transdermal/Transmucosal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Type (2015-2020)
Figure 29. Global Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Application (2015-2020)
Figure 31. Global Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type in 2019
Figure 33. United States Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type in 2019
Figure 34. Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company in 2019
Figure 35. Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type in 2019
Figure 36. Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application in 2019
Figure 37. China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company in 2019
Figure 38. China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type in 2019
Figure 39. China Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application in 2019
Figure 40. Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company in 2019
Figure 41. Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type in 2019
Figure 42. Japan Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application in 2019
Figure 43. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company in 2019
Figure 44. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type in 2019
Figure 45. Southeast Asia Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application in 2019
Figure 46. India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Company in 2019
Figure 47. India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type in 2019
Figure 48. India Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application in 2019
Figure 49. 3M Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Aveva Drug Delivery Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Corium International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. DURECT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Pantec Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Tapemark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Tesa Labtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Zosano Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Transdermal/Transmucosal Drug Delivery System
Figure 62. Manufacturing Process Analysis of Transdermal/Transmucosal Drug Delivery System
Figure 63. Transdermal/Transmucosal Drug Delivery System Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed